Heng Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Heng Zhang has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Zhe Zheng
State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
10 shared publications Sheng Liu
National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Department of Cardiovascular Surgery (Z. Li, C.Y., H.L., S.W., X.H., F.X., X.Y., S.L., Y.Y., H.Z., Y. Zhang, Y. Zhao, Z. Zheng), Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
6 shared publicationsHaojie Li
National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Department of Cardiovascular Surgery (Z. Li, C.Y., H.L., S.W., X.H., F.X., X.Y., S.L., Y.Y., H.Z., Y. Zhang, Y. Zhao, Z. Zheng), Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
5 shared publicationsYan Zhao
National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Department of Cardiovascular Surgery (Z. Li, C.Y., H.L., S.W., X.H., F.X., X.Y., S.L., Y.Y., H.Z., Y. Zhang, Y. Zhao, Z. Zheng), Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
5 shared publicationsHongyan Zhou
National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Department of Cardiovascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
4 shared publicationsJiawei Han
National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
4 shared publications
Latest Publications
- 17 November 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 154 (20) , 2001-2010
Biatrial Versus Left Atrial Maze Ablation During Cardiac Valve Surgery for Persistent Atrial Fibrillation: The ABLATION Trial
BACKGROUND: Guidelines recommend concomitant surgical ablation during cardiac surgery in patients with atrial fibrillation (AF). However, the optimal lesion set remains uncertain, with ongoing debate regarding the relative benefits and risks of biatrial versus left atrial (LA) maze ablation. METHODS: In this multicenter, randomized, single-blind trial, patients with persistent or long-standing persistent AF undergoing rheumatic mitral valve surgery, with or without concomitant cardiac surgical procedures, were randomly assigned in a 1:1 ratio to undergo biatrial or LA maze ablation. The biatrial group underwent a complete Cox-Maze IV procedure; the LA group received a left-sided maze lesion set. To ensure standardization and consistency of the ablation procedures, surgeons underwent pretrial training and certification, and all procedures were videorecorded and centrally reviewed. The primary outcome was freedom from atrial tachyarrhythmias lasting >30 seconds without antiarrhythmic drugs within 12 months. The key secondary end point was freedom from permanent pacemaker implantation. RESULTS: All 323 randomized patients were included in the intention-to-treat analysis (mean age, 56.5 years; 72.1% women; mean LA diameter, 51.9 mm). At 12 months, 78.7% of patients (129 of 164) in the biatrial group and 68.6% (109 of 159) in the LA group were free from atrial tachyarrhythmias (adjusted difference, 10.7% [1-sided lower 95% CI, 3%]; P =0.01). Freedom from permanent pacemaker implantation was noted in 97.0% (159 of 164) of the biatrial group and 98.1% (156 of 159) of the LA group, meeting the predefined noninferiority criterion with a margin of −5% (adjusted difference, –1.1% [1-sided lower 95% CI, –3.9%]; P noninferiority =0.01). CONCLUSIONS: Among patients with persistent or long-standing persistent AF undergoing rheumatic cardiac valve surgery, biatrial maze ablation was superior to LA maze ablation in reducing recurrent atrial tachyarrhythmias, while maintaining noninferiority with respect to permanent pacemaker implantation. These findings provide direct evidence to inform lesion-set selection for surgical ablation during cardiac surgery. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05021601.
- 17 November 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 154 (20) , 2001-2010
Biatrial Versus Left Atrial Maze Ablation During Cardiac Valve Surgery for Persistent Atrial Fibrillation: The ABLATION Trial
BACKGROUND: Guidelines recommend concomitant surgical ablation during cardiac surgery in patients with atrial fibrillation (AF). However, the optimal lesion set remains uncertain, with ongoing debate regarding the relative benefits and risks of biatrial versus left atrial (LA) maze ablation. METHODS: In this multicenter, randomized, single-blind trial, patients with persistent or long-standing persistent AF undergoing rheumatic mitral valve surgery, with or without concomitant cardiac surgical procedures, were randomly assigned in a 1:1 ratio to undergo biatrial or LA maze ablation. The biatrial group underwent a complete Cox-Maze IV procedure; the LA group received a left-sided maze lesion set. To ensure standardization and consistency of the ablation procedures, surgeons underwent pretrial training and certification, and all procedures were videorecorded and centrally reviewed. The primary outcome was freedom from atrial tachyarrhythmias lasting >30 seconds without antiarrhythmic drugs within 12 months. The key secondary end point was freedom from permanent pacemaker implantation. RESULTS: All 323 randomized patients were included in the intention-to-treat analysis (mean age, 56.5 years; 72.1% women; mean LA diameter, 51.9 mm). At 12 months, 78.7% of patients (129 of 164) in the biatrial group and 68.6% (109 of 159) in the LA group were free from atrial tachyarrhythmias (adjusted difference, 10.7% [1-sided lower 95% CI, 3%]; P =0.01). Freedom from permanent pacemaker implantation was noted in 97.0% (159 of 164) of the biatrial group and 98.1% (156 of 159) of the LA group, meeting the predefined noninferiority criterion with a margin of −5% (adjusted difference, –1.1% [1-sided lower 95% CI, –3.9%]; P noninferiority =0.01). CONCLUSIONS: Among patients with persistent or long-standing persistent AF undergoing rheumatic cardiac valve surgery, biatrial maze ablation was superior to LA maze ablation in reducing recurrent atrial tachyarrhythmias, while maintaining noninferiority with respect to permanent pacemaker implantation. These findings provide direct evidence to inform lesion-set selection for surgical ablation during cardiac surgery. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05021601.
- 26 September 2026
- Published by Elsevier in American Heart Journal
- Vol. 304, 107615
Efficacy of perioperative recombinant human brain natriuretic peptide for preventing acute kidney injury after cardiac surgery: Rationale, design, and study protocol for a multicenter, double-blind, randomized controlled trial (PROTECT-CS)
- 26 September 2026
- Published by Elsevier in American Heart Journal
- Vol. 304, 107615
Efficacy of perioperative recombinant human brain natriuretic peptide for preventing acute kidney injury after cardiac surgery: Rationale, design, and study protocol for a multicenter, double-blind, randomized controlled trial (PROTECT-CS)
- Open Access
- 7 September 2026
- Published by S. Karger AG in Kidney Diseases
Postoperative Hyperglycemia and Acute Kidney Injury in Patients Undergoing Coronary Artery Bypass Grafting
Introduction: Acute kidney injury (AKI) is a prevalent and detrimental complication following cardiac surgery, with significant effects on both in-hospital and long-term morbidity and mortality. This study aims to evaluate the association between postoperative hyperglycemia and the risk of AKI following coronary artery bypass grafting (CABG). Methods: This retrospective cohort study included patients undergoing CABG from January 2013 to December 2021. Postoperative hyperglycemia was defined as blood glucose levels ≥ 150 mg/dL for ≥ 3 hours in the first 72 hours after surgery. The primary outcome was AKI within the 7 days after surgery. Propensity scores matching and generalized linear mixed models were performed to assess the association between hyperglycemia and outcomes. Results: Among the included 32,742 patients, 8,600 (26.3%) patients were classified as postoperative normoglycemia. Postoperative normoglycemia was associated with a significantly decreased risk of AKI (47.2% vs 52.2%; aRR, 0.91 [95% CI, 0.88 to 0.93]; P < 0.001). Furthermore, the occurrence of in-hospital major adverse cardiovascular and kidney events (MACKEs) was statistically lower in patients without postoperative hyperglycemia (3.7% vs 5.1%; aRR, 0.74 [95% CI, 0.64 to 0.86]; P < 0.001). Importantly, the association was more pronounced in patients without preexisting diabetes. Conclusions: Among patients undergoing CABG, postoperative hyperglycemia is associated with a higher risk of AKI and in-hospital MACKEs. This effect of is more pronounced in patients without preexisting diabetes. These findings support further investigation of targeted glycemic control, with a specific focus on distinct patient populations.
- 7 September 2026
- Published by S. Karger AG in Kidney Diseases
Open AccessPostoperative Hyperglycemia and Acute Kidney Injury in Patients Undergoing Coronary Artery Bypass Grafting
Introduction: Acute kidney injury (AKI) is a prevalent and detrimental complication following cardiac surgery, with significant effects on both in-hospital and long-term morbidity and mortality. This study aims to evaluate the association between postoperative hyperglycemia and the risk of AKI following coronary artery bypass grafting (CABG). Methods: This retrospective cohort study included patients undergoing CABG from January 2013 to December 2021. Postoperative hyperglycemia was defined as blood glucose levels ≥ 150 mg/dL for ≥ 3 hours in the first 72 hours after surgery. The primary outcome was AKI within the 7 days after surgery. Propensity scores matching and generalized linear mixed models were performed to assess the association between hyperglycemia and outcomes. Results: Among the included 32,742 patients, 8,600 (26.3%) patients were classified as postoperative normoglycemia. Postoperative normoglycemia was associated with a significantly decreased risk of AKI (47.2% vs 52.2%; aRR, 0.91 [95% CI, 0.88 to 0.93]; P < 0.001). Furthermore, the occurrence of in-hospital major adverse cardiovascular and kidney events (MACKEs) was statistically lower in patients without postoperative hyperglycemia (3.7% vs 5.1%; aRR, 0.74 [95% CI, 0.64 to 0.86]; P < 0.001). Importantly, the association was more pronounced in patients without preexisting diabetes. Conclusions: Among patients undergoing CABG, postoperative hyperglycemia is associated with a higher risk of AKI and in-hospital MACKEs. This effect of is more pronounced in patients without preexisting diabetes. These findings support further investigation of targeted glycemic control, with a specific focus on distinct patient populations.
- 8 April 2026
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (42) , 6332-6335
Perioperative dapagliflozin in diabetic patients undergoing cardiac surgery: the DAPA-CS trial
- 8 April 2026
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (42) , 6332-6335
Perioperative dapagliflozin in diabetic patients undergoing cardiac surgery: the DAPA-CS trial
- Open Access
Effect of Prophylactic Care Bundle on Acute Kidney Injury Following Coronary Artery Bypass Grafting
BACKGROUND: Acute kidney injury (AKI) following cardiac surgery is common, yet no consistently effective preventive strategy has been established. Therefore, the aim of this study was to assess the effectiveness of perioperative care bundle in preventing AKI following cardiac surgery. METHODS: The study included consecutive low-risk and high-risk patients who underwent coronary artery bypass grafting (CABG) at China National Center for Cardiovascular Diseases from January 1, 2020, to September 30, 2022. The intervention consisted of a structured care bundle based on Kidney Disease: Improving Global Outcomes guidelines, including close hemodynamic monitoring, goal-directed fluid management, avoidance of nephrotoxins, temporary discontinuation of angiotensin-converting-enzyme inhibitors/angiotensin II receptor blockers for 48 h, serial monitoring of serum creatinine and urine output, and prevention of hyperglycemia. The primary outcome was AKI within 7 days post-surgery. The secondary outcome was in-hospital major adverse cardiac and kidney events (composite of death, renal replacement therapy, >200% creatinine increase, myocardial infarction, or stroke). RESULTS: Of 8,603 patients (2,462 receiving bundle care; 6,141 usual care), 2,416 propensity-matched pairs were analyzed. Mean age was 60.2 years (bundle: standard deviation [SD] 8.9; usual care: SD 9.0); 16.5% vs. 16.3% were women. AKI risk was significantly lower with bundle care vs. usual care (53.1% vs. 59.9%; mean difference, –6.8% [95% confidence interval (CI), –9.6% to –0.4%]; relative risk [RR], 0.89 [95% CI, 0.84 to 0.93]; P < .001). Bundle care also reduced major adverse cardiac and kidney events (4.7% vs. 6.3%; mean difference, −1.6% [95% CI, −2.9% to −0.3%]; RR, 0.75 [95% CI, 0.59 to 0.95]; P = .02). Benefits were more pronounced in high-risk patients (for AKI, RR, 0.89 [95% CI, 0.84 to 0.95]; P < .001; for major adverse cardiac and kidney events, RR, 0.74 [95% CI, 0.55 to 1.00]; P = .04). No statistically significant difference in all-cause mortality was observed. CONCLUSIONS: Among patients undergoing CABG, perioperative care bundle strategy, compared with standard care, was significantly associated with a lower risk of AKI and in-hospital major adverse cardiac and kidney events. Randomized clinical trials are warranted to confirm these findings.
Open AccessEffect of Prophylactic Care Bundle on Acute Kidney Injury Following Coronary Artery Bypass Grafting
BACKGROUND: Acute kidney injury (AKI) following cardiac surgery is common, yet no consistently effective preventive strategy has been established. Therefore, the aim of this study was to assess the effectiveness of perioperative care bundle in preventing AKI following cardiac surgery. METHODS: The study included consecutive low-risk and high-risk patients who underwent coronary artery bypass grafting (CABG) at China National Center for Cardiovascular Diseases from January 1, 2020, to September 30, 2022. The intervention consisted of a structured care bundle based on Kidney Disease: Improving Global Outcomes guidelines, including close hemodynamic monitoring, goal-directed fluid management, avoidance of nephrotoxins, temporary discontinuation of angiotensin-converting-enzyme inhibitors/angiotensin II receptor blockers for 48 h, serial monitoring of serum creatinine and urine output, and prevention of hyperglycemia. The primary outcome was AKI within 7 days post-surgery. The secondary outcome was in-hospital major adverse cardiac and kidney events (composite of death, renal replacement therapy, >200% creatinine increase, myocardial infarction, or stroke). RESULTS: Of 8,603 patients (2,462 receiving bundle care; 6,141 usual care), 2,416 propensity-matched pairs were analyzed. Mean age was 60.2 years (bundle: standard deviation [SD] 8.9; usual care: SD 9.0); 16.5% vs. 16.3% were women. AKI risk was significantly lower with bundle care vs. usual care (53.1% vs. 59.9%; mean difference, –6.8% [95% confidence interval (CI), –9.6% to –0.4%]; relative risk [RR], 0.89 [95% CI, 0.84 to 0.93]; P < .001). Bundle care also reduced major adverse cardiac and kidney events (4.7% vs. 6.3%; mean difference, −1.6% [95% CI, −2.9% to −0.3%]; RR, 0.75 [95% CI, 0.59 to 0.95]; P = .02). Benefits were more pronounced in high-risk patients (for AKI, RR, 0.89 [95% CI, 0.84 to 0.95]; P < .001; for major adverse cardiac and kidney events, RR, 0.74 [95% CI, 0.55 to 1.00]; P = .04). No statistically significant difference in all-cause mortality was observed. CONCLUSIONS: Among patients undergoing CABG, perioperative care bundle strategy, compared with standard care, was significantly associated with a lower risk of AKI and in-hospital major adverse cardiac and kidney events. Randomized clinical trials are warranted to confirm these findings.
- Open Access
- 2 May 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (5) , ytae158
Left atrial appendage aneurysm with atrial fibrillation: a case report
A 61-year-old woman presented with a history of increasing dyspnoea along with palpitation for 7 years. When she hospitalized in our institution in 2015, she received transcatheter paroxysmal atrial fibrillation ablation, during which a diagnosis of a congenital left atrial appendage aneurysm (LAAA, 8.1 × 4.6 cm by computed tomography) was made and was treated conservatively according to the patient’s preference (Figure 1A). In 2017, the atrial fibrillation recurred, and she began to receive oral anticoagulant therapy during the following years. She was hospitalized with the initial treatment plan for repeat transcatheter atrial fibrillation ablation in 2022. Medical re-examination with transthoracic echocardiography showed left atrial appendage thrombus, and computed tomography demonstrated a giant (7.9 × 6.1 cm) saccular aneurysm containing thrombus (Figure 1B–D), communicating with the left atrium through a broad neck. During the hospitalization, she presented with an acute persistent abdominal pain, caused by right renal artery embolism that might be related to detachment of left atrial thrombus. Emergency renal artery balloon dilation was performed, and the embolism was removed (Figure 1E). Therefore, surgical resection of the LAAA was recommended based on the symptoms, recurred atrial fibrillation, as well as thrombus formation. The aneurysm was resected, and the aneurismal neck was closed with continuous suture (Figure 1F), meanwhile a maze procedure was performed. Histological findings demonstrated marked thinning of the left atrial appendage wall with increased fibrous tissue consistent with an aneurysm. The post-operative course was uneventful, and the patient regained sinus rhythm, with improvement of global and regional LV function. She remained on a regimen of low-dose rivaroxaban (10 mg twice a day) post-operatively and was discharged without clinical symptoms.
- 2 May 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (5) , ytae158
Open AccessLeft atrial appendage aneurysm with atrial fibrillation: a case report
A 61-year-old woman presented with a history of increasing dyspnoea along with palpitation for 7 years. When she hospitalized in our institution in 2015, she received transcatheter paroxysmal atrial fibrillation ablation, during which a diagnosis of a congenital left atrial appendage aneurysm (LAAA, 8.1 × 4.6 cm by computed tomography) was made and was treated conservatively according to the patient’s preference (Figure 1A). In 2017, the atrial fibrillation recurred, and she began to receive oral anticoagulant therapy during the following years. She was hospitalized with the initial treatment plan for repeat transcatheter atrial fibrillation ablation in 2022. Medical re-examination with transthoracic echocardiography showed left atrial appendage thrombus, and computed tomography demonstrated a giant (7.9 × 6.1 cm) saccular aneurysm containing thrombus (Figure 1B–D), communicating with the left atrium through a broad neck. During the hospitalization, she presented with an acute persistent abdominal pain, caused by right renal artery embolism that might be related to detachment of left atrial thrombus. Emergency renal artery balloon dilation was performed, and the embolism was removed (Figure 1E). Therefore, surgical resection of the LAAA was recommended based on the symptoms, recurred atrial fibrillation, as well as thrombus formation. The aneurysm was resected, and the aneurismal neck was closed with continuous suture (Figure 1F), meanwhile a maze procedure was performed. Histological findings demonstrated marked thinning of the left atrial appendage wall with increased fibrous tissue consistent with an aneurysm. The post-operative course was uneventful, and the patient regained sinus rhythm, with improvement of global and regional LV function. She remained on a regimen of low-dose rivaroxaban (10 mg twice a day) post-operatively and was discharged without clinical symptoms.
- Open Access
- 7 March 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 80 (1) , 153-162.e4
Association of carotid duplex ultrasonography screening with stroke and mortality among patients undergoing coronary artery bypass grafting
- 7 March 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 80 (1) , 153-162.e4
Open AccessAssociation of carotid duplex ultrasonography screening with stroke and mortality among patients undergoing coronary artery bypass grafting
- Open Access
- 23 June 2021
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 33 (3) , 354-361
Midterm results of stand-alone thoracoscopic epicardial ablation with box lesion for atrial fibrillation
The short-term results of video-assisted thoracoscopic surgical ablation (VTSA) with box lesion have been highly variable, and the actual efficacy requires clarification through longer follow-ups. We aimed to report which patients might benefit more from VTSA with box lesion by longer follow-up. From September 2010 to November 2016, patients with atrial fibrillation (AF) who underwent VTSA with box lesion were screened. All enrolled patients visited the outpatient clinic and underwent 24-h Holter monitoring at 3, 6 and 12 months after surgery and annually thereafter. A total of 91 consecutive patients [age, 58.0 (interquartile interval from 52.0 to 62.0) years; male, 71.4%] with paroxysmal (67%) or persistent/long-standing persistent (33%) AF were enrolled. After a median follow-up of 48 months (interquartile interval from 36 to 60 months), freedom from atrial tachyarrhythmias without antiarrhythmic drugs (AADs) was 76.5%, 66.0% and 66.0% for paroxysmal AF and 58.6%, 47.8% and 34.2% for persistent/long-standing persistent AF at 12, 36 and 60 months, respectively (P = 0.017). The preoperative left atrial diameter >40 mm (hazard ratio: 2.837, 95% confidence interval: 1.408–5.716; P = 0.004) and age >50 years (hazard ratio: 2.927, 95% confidence interval: 1.359–6.305; P = 0.006) were associated with recurrences of atrial tachyarrhythmias. In patients with paroxysmal AF and left atrial diameter ≤40 mm (n = 43), freedom from atrial tachyarrhythmias without AADs was 81.4%, 74.3% and 74.3% at 12, 36 and 60 months, respectively. In patients with paroxysmal AF and left atrial diameter ≤40 mm, 5-year freedom from atrial tachyarrhythmias without AADs was 74.3%, which was better than that in patients with left atrial diameter >40 mm. A larger sample size and improved study design are needed to confirm our conclusions.
- 23 June 2021
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 33 (3) , 354-361
Open AccessMidterm results of stand-alone thoracoscopic epicardial ablation with box lesion for atrial fibrillation
The short-term results of video-assisted thoracoscopic surgical ablation (VTSA) with box lesion have been highly variable, and the actual efficacy requires clarification through longer follow-ups. We aimed to report which patients might benefit more from VTSA with box lesion by longer follow-up. From September 2010 to November 2016, patients with atrial fibrillation (AF) who underwent VTSA with box lesion were screened. All enrolled patients visited the outpatient clinic and underwent 24-h Holter monitoring at 3, 6 and 12 months after surgery and annually thereafter. A total of 91 consecutive patients [age, 58.0 (interquartile interval from 52.0 to 62.0) years; male, 71.4%] with paroxysmal (67%) or persistent/long-standing persistent (33%) AF were enrolled. After a median follow-up of 48 months (interquartile interval from 36 to 60 months), freedom from atrial tachyarrhythmias without antiarrhythmic drugs (AADs) was 76.5%, 66.0% and 66.0% for paroxysmal AF and 58.6%, 47.8% and 34.2% for persistent/long-standing persistent AF at 12, 36 and 60 months, respectively (P = 0.017). The preoperative left atrial diameter >40 mm (hazard ratio: 2.837, 95% confidence interval: 1.408–5.716; P = 0.004) and age >50 years (hazard ratio: 2.927, 95% confidence interval: 1.359–6.305; P = 0.006) were associated with recurrences of atrial tachyarrhythmias. In patients with paroxysmal AF and left atrial diameter ≤40 mm (n = 43), freedom from atrial tachyarrhythmias without AADs was 81.4%, 74.3% and 74.3% at 12, 36 and 60 months, respectively. In patients with paroxysmal AF and left atrial diameter ≤40 mm, 5-year freedom from atrial tachyarrhythmias without AADs was 74.3%, which was better than that in patients with left atrial diameter >40 mm. A larger sample size and improved study design are needed to confirm our conclusions.
- Open Access
- 1 April 2021
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 14 (4)
Trends of Coronary Artery Bypass Grafting Performance in a Cohort of Hospitals in China Between 2013 and 2018
Background: China has witnessed a rapid increase in the volume of coronary artery bypass grafting (CABG) but substantial gaps in the performance for CABG across the nation. The present study aimed to investigate the change in CABG performance after years of quality improvement measures in a national registry in China. Methods: The study included 66 971 patients who underwent isolated CABG in a cohort of 74 tertiary hospitals in China between January 2013 and December 2018. Data were collected from the Chinese Cardiac Surgery Registry. Outcomes were in-hospital mortality and postoperative length of stay. Five process measures for surgical technique and secondary prevention were also analyzed. We described the changes in the overall performance and interhospital heterogeneity across the years. Results: The in-hospital mortality declined from 0.9% in 2013 to 0.6 in 2018, with a risk-adjusted odds ratio of 0.66 (95% CI, 0.46–0.93; P <0.001). The standard mean difference for risk-standardized mortality rate between hospitals in the lowest and highest quartile narrowed from 1.63 in 2013 to 1.35 in 2018. The median (interquartile range) hospital-level rate of using arterial graft increased from 93.9% (86.0%–97.8%) to 94.6% (83.3%–99.2%), but the difference was not statistically significant. Meanwhile, the rate of free from blood transfusion increased from 17.0% (2.6%–32.0%) to 34.1% (8.8%–52.9%). The hospital-level rate of prescribing β-blockers at discharge significantly increased from 82.8% (66.7%–90.3%) to 91.1% (82.1%–97.1%), statin from 75.8% (55.7%–88.9%) to 88.9% (75.0%–96.0%), and aspirin from 90.3% (83.9%–95.2%) to 95.3% (88.9%–98.1%). Conclusions: In the Chinese Cardiac Surgery Registry, there were notable improvements in the treatment process related to CABG and decline of in-hospital mortality with reduced interhospital heterogeneity.
- 1 April 2021
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 14 (4)
Open AccessTrends of Coronary Artery Bypass Grafting Performance in a Cohort of Hospitals in China Between 2013 and 2018
Background: China has witnessed a rapid increase in the volume of coronary artery bypass grafting (CABG) but substantial gaps in the performance for CABG across the nation. The present study aimed to investigate the change in CABG performance after years of quality improvement measures in a national registry in China. Methods: The study included 66 971 patients who underwent isolated CABG in a cohort of 74 tertiary hospitals in China between January 2013 and December 2018. Data were collected from the Chinese Cardiac Surgery Registry. Outcomes were in-hospital mortality and postoperative length of stay. Five process measures for surgical technique and secondary prevention were also analyzed. We described the changes in the overall performance and interhospital heterogeneity across the years. Results: The in-hospital mortality declined from 0.9% in 2013 to 0.6 in 2018, with a risk-adjusted odds ratio of 0.66 (95% CI, 0.46–0.93; P <0.001). The standard mean difference for risk-standardized mortality rate between hospitals in the lowest and highest quartile narrowed from 1.63 in 2013 to 1.35 in 2018. The median (interquartile range) hospital-level rate of using arterial graft increased from 93.9% (86.0%–97.8%) to 94.6% (83.3%–99.2%), but the difference was not statistically significant. Meanwhile, the rate of free from blood transfusion increased from 17.0% (2.6%–32.0%) to 34.1% (8.8%–52.9%). The hospital-level rate of prescribing β-blockers at discharge significantly increased from 82.8% (66.7%–90.3%) to 91.1% (82.1%–97.1%), statin from 75.8% (55.7%–88.9%) to 88.9% (75.0%–96.0%), and aspirin from 90.3% (83.9%–95.2%) to 95.3% (88.9%–98.1%). Conclusions: In the Chinese Cardiac Surgery Registry, there were notable improvements in the treatment process related to CABG and decline of in-hospital mortality with reduced interhospital heterogeneity.
- 25 January 2021
- Published by Springer Nature in Pituitary
- Vol. 24 (3) , 457-464
Diagnostic value of Knosp grade and modified Knosp grade for cavernous sinus invasion in pituitary adenomas: a systematic review and meta‐analysis
Objective This study aimed to examine the reliability of existing Knosp grade (KG) and modified KG for cavernous sinus invasion (CSI). Methods A thorough search of literature from 1993 to 2020 in six databases was performed. Studies that reported the intraoperative confirmation of CSI using KG and/or modified KG were included. The pooled estimates were calculated by meta-analysis with a bivariate mixed-effect model and the assessment of heterogeneity with I2 statistic. Results The final search yielded 12 eligible studies, which enrolled 3006 patients assessed with KG and 1315 patients assessed with modified KG. The results of the area under the receiver operating characteristic curve showed the good discriminative abilities of grades 2–4 (0.90), 3–4 (0.86) and 3B–4 (0.91) in predicting CSI. Grade 3A showed a remarkably lower CSI rate (44% versus 81%) and incomplete resection rate (26% versus 52%) than grade 3B. Grades 0 and 1 showed a low CSI rate. CSI and incomplete resection rates in grade 2 (30% and 21%, respectively) were close to those in grade 3A. Conclusions Modifying the KG improved its prognostic role in CSI and gross total resection. However, these grading systems cannot be used as the group standard for invasive and non-invasive pituitary adenomas (PAs) because of the weak reliability of the scale’s middle grades (grades 2 and 3A). Authors of future PA studies should consider reporting KG as high (grades 3B and 4), medium (grades 2 and 3A) and low (grades 0 and 1) to optimise the application of the scale.
- 25 January 2021
- Published by Springer Nature in Pituitary
- Vol. 24 (3) , 457-464
Diagnostic value of Knosp grade and modified Knosp grade for cavernous sinus invasion in pituitary adenomas: a systematic review and meta‐analysis
Objective This study aimed to examine the reliability of existing Knosp grade (KG) and modified KG for cavernous sinus invasion (CSI). Methods A thorough search of literature from 1993 to 2020 in six databases was performed. Studies that reported the intraoperative confirmation of CSI using KG and/or modified KG were included. The pooled estimates were calculated by meta-analysis with a bivariate mixed-effect model and the assessment of heterogeneity with I2 statistic. Results The final search yielded 12 eligible studies, which enrolled 3006 patients assessed with KG and 1315 patients assessed with modified KG. The results of the area under the receiver operating characteristic curve showed the good discriminative abilities of grades 2–4 (0.90), 3–4 (0.86) and 3B–4 (0.91) in predicting CSI. Grade 3A showed a remarkably lower CSI rate (44% versus 81%) and incomplete resection rate (26% versus 52%) than grade 3B. Grades 0 and 1 showed a low CSI rate. CSI and incomplete resection rates in grade 2 (30% and 21%, respectively) were close to those in grade 3A. Conclusions Modifying the KG improved its prognostic role in CSI and gross total resection. However, these grading systems cannot be used as the group standard for invasive and non-invasive pituitary adenomas (PAs) because of the weak reliability of the scale’s middle grades (grades 2 and 3A). Authors of future PA studies should consider reporting KG as high (grades 3B and 4), medium (grades 2 and 3A) and low (grades 0 and 1) to optimise the application of the scale.